A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China
Clinical trial NCT04477772 · COMPLETED
Trial details
- NCT number
- NCT04477772
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-17
- Primary completion
- 2024-03-14
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.